Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells.
Cytomegalovirus (CMV) infection has been linked to inflammation-related disease processes in the human host, including vascular diseases and chronic transplant rejection. The mechanisms through which CMV affects the pathogenesis of these diseases are for the most part unknown. To study the contributing role of the host immune response to CMV in these chronic inflammatory processes, we examined endothelial cell interactions with peripheral blood mononuclear cells (PBMC). Endothelial cultures were monitored for levels of fractalkine induction as a marker for initiating the host inflammatory response. Our results demonstrate that in the presence of CMV antigen PBMC from normal healthy CMV-seropositive donors produce soluble factors that induce fractalkine in endothelial cells. This was not observed in parallel assays with PBMC from seronegative donors. Examination of subset populations within the PBMC further revealed that CMV antigen-stimulated CD4(+) T cells were the source of the factors, gamma interferon and tumor necrosis factor alpha, driving fractalkine induction. Direct contact between CD4(+) cells and the endothelial monolayers is required for this fractalkine induction, where the endothelial cells appear to provide antigen presentation functions. These findings indicate that CMV may represent one member of a class of persistent pathogens where the antigen-specific T-cell response can result in the induction of fractalkine, leading to chronic inflammation and endothelial cell injury.
Bolovan-Fritts
Cynthia A
CA
Department of Pediatrics, University of California at San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0672, USA.
Trout
Rodney N
RN
Spector
Stephen A
SA
D000956:Antigens, Viral / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002478:Cells, Cultured; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C / Q000096:biosynthesis*; D016207:Cytokines / Q000096:biosynthesis*; D003587:Cytomegalovirus / Q000276:immunology*; D042783:Endothelial Cells / Q000378:metabolism*; D006801:Humans; D007371:Interferon-gamma / Q000502:physiology; D018950:Lipopolysaccharide Receptors / Q000032:analysis; D008565:Membrane Proteins / Q000096:biosynthesis*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D000956:Antigens, Viral; C515538:CX3CL1 protein, human; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C; D016207:Cytokines; D018950:Lipopolysaccharide Receptors; D008565:Membrane Proteins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma